Judith A Kelleher

Title: Judith A Kelleher: Innovator in Neurodegenerative Disease Treatment

Introduction

Judith A Kelleher is a prominent inventor based in Irvine, California. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented methods. With a total of two patents to her name, Kelleher's work focuses on the treatment of conditions such as Alzheimer's disease.

Latest Patents

Kelleher's latest patents include groundbreaking methods for treating neurodegenerative diseases. One patent details the use of metabotropic receptor agonists in progressive neurodegenerative conditions. This method involves administering a metabotropic receptor agonist, specifically trans-ACPD or 1S,3R-ACPD, intravenously to mammals suffering from Alzheimer's disease. Another patent addresses the inhibition of beta-amyloid toxicity in brain cells. This method includes administering an alkaline phosphatase inhibitor to reduce degeneration in the cells, along with methods for treating peripheral neuropathy using acid or alkaline phosphatase inhibitors.

Career Highlights

Kelleher's career is marked by her dedication to advancing medical treatments for neurodegenerative diseases. Her work at Cortex Pharmaceuticals, Inc. has positioned her as a key figure in the development of innovative therapies. Her research has the potential to significantly impact the lives of individuals affected by these debilitating conditions.

Collaborations

Kelleher has collaborated with notable colleagues, including David D Eveleth and Carl W Cotman. These partnerships have further enhanced her research and contributed to the advancement of her patented methods.

Conclusion

Judith A Kelleher is a trailblazer in the field of neurodegenerative disease treatment, with her innovative patents paving the way for new therapeutic approaches. Her contributions continue to inspire advancements in medical research and treatment options.